| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Debby Handayati Harahap, Carla Raymondalexas Marchira, Eti Nurwening Solikhah, Dicky Moch Riza. The role of aripiprazole in improvement of penile erection in schizophrenia patients with erectile dysfunction. Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina. vol 18. issue 2. 2021-09-07. PMID:33871221. |
aim to provide evidence regarding the effectiveness of aripiprazole in improving penile erection with a therapeutic strategy of add-on or switching therapy in patients with schizophrenia. |
2021-09-07 |
2023-08-13 |
Not clear |
| Debby Handayati Harahap, Carla Raymondalexas Marchira, Eti Nurwening Solikhah, Dicky Moch Riza. The role of aripiprazole in improvement of penile erection in schizophrenia patients with erectile dysfunction. Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina. vol 18. issue 2. 2021-09-07. PMID:33871221. |
pubmed, cochrane, clinical key, proquest, ebscohost, and sciencedirect were searched for any design study that evaluated aripiprazole only or versus control (placebo or other antipsychotic) for erectile dysfunction in patients with schizophrenia. |
2021-09-07 |
2023-08-13 |
Not clear |
| Debby Handayati Harahap, Carla Raymondalexas Marchira, Eti Nurwening Solikhah, Dicky Moch Riza. The role of aripiprazole in improvement of penile erection in schizophrenia patients with erectile dysfunction. Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina. vol 18. issue 2. 2021-09-07. PMID:33871221. |
conclusion aripiprazole was effective to improve penile erectile function in patients with schizophrenia. |
2021-09-07 |
2023-08-13 |
Not clear |
| Hiroyuki Fujiyama, Hiroko Sugawara, Teppei Kanno, Kazuhiro Kawahara, Hibiki Tanaka, Ryuji Fukuhara, Shuken Boku, Minoru Takebayash. Combination therapy of brexpiprazole and aripiprazole for an adolescent patient with a first episode of schizophrenia: A case report. Psychiatry and clinical neurosciences. vol 74. issue 12. 2021-09-06. PMID:32909325. |
combination therapy of brexpiprazole and aripiprazole for an adolescent patient with a first episode of schizophrenia: a case report. |
2021-09-06 |
2023-08-13 |
Not clear |
| Li Qian, Liao Xuemei, Li Jitao, Su Yun'Ai, Si Tianme. Dose-Dependent Efficacy of Aripiprazole in Treating Patients With Schizophrenia or Schizoaffective Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in psychiatry. vol 12. 2021-08-31. PMID:34456770. |
dose-dependent efficacy of aripiprazole in treating patients with schizophrenia or schizoaffective disorder: a systematic review and meta-analysis of randomized controlled trials. |
2021-08-31 |
2023-08-13 |
Not clear |
| Paula Soria-Chacartegui, Gonzalo Villapalos-García, Pablo Zubiaur, Francisco Abad-Santos, Dora Kolle. Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. Frontiers in pharmacology. vol 12. 2021-08-03. PMID:34335273. |
olanzapine, aripiprazole and risperidone are atypical antipsychotics or neuroleptics widely used for schizophrenia treatment. |
2021-08-03 |
2023-08-13 |
Not clear |
| Anna Maria Szota, Izabela Radajewska, Aleksander Stanisław Araszkiewic. Atypical Neuroleptic Malignant Syndrome: Case Reports and Diagnostic Challenges. Journal of psychoactive drugs. 2021-08-03. PMID:34340640. |
atypical neuroleptic malignant syndrome was found to develop mainly in male patients suffering from schizophrenia (14 cases) and bipolar disorder (2), and was induced by clozapine (6 cases), olanzapine (5 cases), aripiprazole and quetiapine (4 cases). |
2021-08-03 |
2023-08-13 |
Not clear |
| Kunal Maini, Haley Gould, Jessica Hicks, Fatima Iqbal, James Patterson, Amber N Edinoff, Elyse M Cornett, Adam M Kaye, Omar Viswanath, Ivan Urits, Alan D Kay. Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review. Neurology international. vol 13. issue 3. 2021-07-24. PMID:34287335. |
aripiprazole lauroxil, a novel injectable long-acting antipsychotic treatment for adults with schizophrenia: a comprehensive review. |
2021-07-24 |
2023-08-13 |
Not clear |
| Kunal Maini, Haley Gould, Jessica Hicks, Fatima Iqbal, James Patterson, Amber N Edinoff, Elyse M Cornett, Adam M Kaye, Omar Viswanath, Ivan Urits, Alan D Kay. Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review. Neurology international. vol 13. issue 3. 2021-07-24. PMID:34287335. |
this is a comprehensive review of the literature regarding the use of aripiprazole lauroxil for schizophrenia. |
2021-07-24 |
2023-08-13 |
Not clear |
| Kunal Maini, Haley Gould, Jessica Hicks, Fatima Iqbal, James Patterson, Amber N Edinoff, Elyse M Cornett, Adam M Kaye, Omar Viswanath, Ivan Urits, Alan D Kay. Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review. Neurology international. vol 13. issue 3. 2021-07-24. PMID:34287335. |
this review presents the background, evidence, and indications for using aripiprazole lauroxil to treat schizophrenia in the context of current theories on the development of schizophrenia. |
2021-07-24 |
2023-08-13 |
Not clear |
| Ilda Bidollari, Alexa Vasios, Amy Claxto. Safety and Tolerability of Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Treatment of Schizophrenia in the ALPINE Study. CNS spectrums. vol 26. issue 2. 2021-07-23. PMID:34127093. |
safety and tolerability of aripiprazole lauroxil 2-month formulation with 1-day initiation for treatment of schizophrenia in the alpine study. |
2021-07-23 |
2023-08-13 |
Not clear |
| Ilda Bidollari, Alexa Vasios, Amy Claxto. Safety and Tolerability of Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Treatment of Schizophrenia in the ALPINE Study. CNS spectrums. vol 26. issue 2. 2021-07-23. PMID:34127093. |
evaluate safety and tolerability of an aripiprazole lauroxil (al) 2-month regimen using 1-day initiation in patients hospitalized for acute exacerbation of schizophrenia and transitioned to outpatient care. |
2021-07-23 |
2023-08-13 |
Not clear |
| Henry Nasrallah, David Walling, Peter J Weiden, Yangchun Du, Baiyun Yao, Sergey Yagoda, Amy Claxto. Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Acute Schizophrenia: ALPINE Exploratory Efficacy and Patient-Reported Outcomes. CNS spectrums. vol 26. issue 2. 2021-07-23. PMID:34127096. |
aripiprazole lauroxil 2-month formulation with 1-day initiation for acute schizophrenia: alpine exploratory efficacy and patient-reported outcomes. |
2021-07-23 |
2023-08-13 |
Not clear |
| Henry Nasrallah, David Walling, Peter J Weiden, Yangchun Du, Baiyun Yao, Sergey Yagoda, Amy Claxto. Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Acute Schizophrenia: ALPINE Exploratory Efficacy and Patient-Reported Outcomes. CNS spectrums. vol 26. issue 2. 2021-07-23. PMID:34127096. |
the randomized, controlled, phase 3b alpine study evaluated efficacy and safety of a 2-month formulation of aripiprazole lauroxil (al) initiated with a 1-day regimen during hospitalization for an acute exacerbation of schizophrenia; paliperidone palmitate (pp) was included as an active control. |
2021-07-23 |
2023-08-13 |
Not clear |
| Lakshmi Priya, Bini Moorth. A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia. Case reports in psychiatry. vol 2021. 2021-07-15. PMID:34258097. |
a case of hypersexuality in a patient receiving aripiprazole for schizophrenia. |
2021-07-15 |
2023-08-13 |
Not clear |
| Lakshmi Priya, Bini Moorth. A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia. Case reports in psychiatry. vol 2021. 2021-07-15. PMID:34258097. |
the case presented is of a 24-year-old male with schizophrenia who developed hypersexuality symptoms after initiation of aripiprazole. |
2021-07-15 |
2023-08-13 |
Not clear |
| Yasin Hasan Balcioglu, Hasan Gokcay, Umit Haluk Yesilkay. One Plus One Sometimes Equals More Than Two: Long-acting Injectable Aripiprazole Adjunction in Clozapine-Resistant Schizophrenia. Clinical neuropharmacology. vol 43. issue 5. 2021-07-08. PMID:32947430. |
one plus one sometimes equals more than two: long-acting injectable aripiprazole adjunction in clozapine-resistant schizophrenia. |
2021-07-08 |
2023-08-13 |
Not clear |
| Yasin Hasan Balcioglu, Hasan Gokcay, Umit Haluk Yesilkay. One Plus One Sometimes Equals More Than Two: Long-acting Injectable Aripiprazole Adjunction in Clozapine-Resistant Schizophrenia. Clinical neuropharmacology. vol 43. issue 5. 2021-07-08. PMID:32947430. |
although we cannot postulate on a single exact mechanism for the increased efficacy of clozapine and aripiprazole combination, we may suggest that, at least for a subgroup of patients with schizophrenia who respond clinically to clozapine at a suboptimal level, combination with aripiprazole may be an effective therapeutic strategy. |
2021-07-08 |
2023-08-13 |
Not clear |
| Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia: Erratum. Journal of clinical psychopharmacology. vol 41. issue 4. 2021-06-29. PMID:34181366. |
association of aripiprazole with reduced hippocampal atrophy during maintenance treatment of first-episode schizophrenia: erratum. |
2021-06-29 |
2023-08-13 |
Not clear |
| Xiaoshuai Ning, Lei Xia, Yudong Shi, Rui Hao, Feng Geng, Kai Zhang, Huanzhong Li. Cognitive improvement function of aripiprazole in adolescents with first-episode and repeated-episode schizophrenia. Asian journal of psychiatry. vol 58. 2021-06-21. PMID:33611084. |
cognitive improvement function of aripiprazole in adolescents with first-episode and repeated-episode schizophrenia. |
2021-06-21 |
2023-08-13 |
Not clear |